Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

449.53 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

70 71 Next >

Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗

July 18, 2025

Via Benzinga

3 Cash-Burning Stocks Walking a Fine Line

July 15, 2025

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

Via StockStory

Topics Bankruptcy Economy

Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain

July 14, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

My 3 Top Stocks to Buy in a Market That's Highly Volatile (Again) ↗

July 14, 2025

Via The Motley Fool

Topics Artificial Intelligence Energy World Trade

The Best Stocks to Invest $1,000 in Right Now ↗

July 12, 2025

Via The Motley Fool

Topics Artificial Intelligence

10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

July 12, 2025

With just a little bit of a deeper look, these businesses are positioned for long-term growth.

Via The Motley Fool

Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗

July 11, 2025

Via The Motley Fool

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

Via Investor Brand Network

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz ↗

July 08, 2025

Via The Motley Fool

Topics Stocks

Vertex to Announce Second Quarter 2025 Financial Results on August 4th

July 08, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

July 07, 2025

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

3 No-Brainer Stocks to Buy in July ↗

July 07, 2025

Via The Motley Fool

The Best Stocks to Invest $1,000 In Right Now ↗

July 05, 2025

Via The Motley Fool

Topics Artificial Intelligence Government

Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU ↗

July 01, 2025

Vertex announced on Tuesday that eligible patients in Ireland, Denmark, and Germany will have access to Alyftrek shortly after receiving regulatory approval from the relevant authorities.

Via Stocktwits

$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗

June 30, 2025

Via Benzinga

How Do Investors Really Feel About Vertex Pharmaceuticals? ↗

June 27, 2025

Via Benzinga

3 S&P 500 Stocks with Mounting Challenges

June 27, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Artificial Intelligence Stocks

Vertex Pharmaceuticals Unusual Options Activity ↗

June 26, 2025

Via Benzinga

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

June 23, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Unpopular Stocks Facing Headwinds

June 23, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

June 20, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering ↗

June 20, 2025

FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research

Via Benzinga

Friday's session: gap up and gap down stock in the S&P500 index ↗

June 20, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

2 Growth Stocks to Buy and Hold for 10 Years ↗

June 19, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy World Trade

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts ↗

June 17, 2025

Via Benzinga

3 Growth Stocks You Can Buy Right Now Without Any Hesitation ↗

June 16, 2025

Via The Motley Fool

$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗

June 10, 2025

Via Benzinga

1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore

June 10, 2025

The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or...

Via StockStory

Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It ↗

June 09, 2025

Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases.

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.